Sign Up to like & get
recommendations!
2
Published in 2023 at "Disease Markers"
DOI: 10.1155/2023/5899662
Abstract: Background Currently, how to successfully control refractory and metastatic diseases remains a fundamental goal for clinicians to improve therapeutic effects for patients with non-small cell lung cancer (NSCLC). Several studies have discovered that TRIM58, a…
read more here.
Keywords:
trim58 zeb1;
zeb1;
zeb1 protein;
tumor ... See more keywords